SR-1903 is a modulator of retinoic acid receptor-related orphan receptor γ (RORγ) and liver X receptor (LXR). It is an inverse agonist of RORγ and an agonist of LXR. It also binds to peroxisome proliferator-activated receptor γ (PPAR) but does not activate it. SR-1903 inhibits LPS-induced expression of triggering receptor expressed on myeloid cells 1 (TREM-1). It also inhibits LPS-induced expression of the LXR target genes IL-6 and IL-33 and increases expression of ABCG1, FASN, and SCD-1. SR-1903 reduces the severity of collagen-induced arthritis. It reduces blood glucose levels in a glucose tolerance test, serum levels of total cholesterol and LDL, body weight, and fat mass in a mouse model of high-fat diet-induced obesity.
MedKoo Cat#: 574023
Name: SR1903 free base
CAS#: 1414248-06-8 (free base)
Chemical Formula: C27H27F6N3O
Exact Mass: 523.2058
Molecular Weight: 523.52
Elemental Analysis: C, 61.95; H, 5.20; F, 21.77; N, 8.03; O, 3.06
Solvent | mg/mL | mM | comments | |
---|---|---|---|---|
Solubility | ||||
DMF | 20.0 | 38.20 | ||
DMSO | 20.0 | 38.20 | ||
Ethanol | 10.0 | 19.10 |
The following data is based on the product molecular weight 523.52 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |